James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), bought 25,000 shares at $5.20 ($130K) on 2024-05-29, disclosed to the SEC on 2024-05-30.
Open-market purchase of $130k TMCI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |
| TMCI | SELL | 2024-03-29 | $1.0M | — | Filing → |